April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Visual Outcomes of Boston Keratoprosthesis Implantation as the Primary Penetrating Corneal Procedure
Author Affiliations & Notes
  • Joann J. Kang
    Ophthalmology, University of Illinois Eye and Ear Infirmary, Chicago, Illinois
  • Maria S. Cortina
    Ophthalmology, University of Illinois Eye and Ear Infirmary, Chicago, Illinois
  • Jose De la Cruz
    Ophthalmology, University of Illinois Eye and Ear Infirmary, Chicago, Illinois
  • Footnotes
    Commercial Relationships  Joann J. Kang, None; Maria S. Cortina, None; Jose De la Cruz, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 341. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Joann J. Kang, Maria S. Cortina, Jose De la Cruz; Visual Outcomes of Boston Keratoprosthesis Implantation as the Primary Penetrating Corneal Procedure. Invest. Ophthalmol. Vis. Sci. 2011;52(14):341.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To report the visual outcomes of keratoprosthesis (KPro) surgery as the primary penetrating corneal procedure for patients at high risk for conventional corneal transplantation.

Methods: : A retrospective chart review was conducted of 69 eyes of 67 patients who underwent either type I or type II Boston KPro surgery from February 2007 to November 2010 at our institution. Of these, 15 eyes of 14 patients underwent KPro as the primary penetrating corneal procedure. The medical records were reviewed to assess preoperative vision, intraoperative and postoperative complications, and uncorrected and best-corrected visual acuities (BCVA).

Results: : Fourteen type I (93.3%) and 1 type II (6.7%) Boston KPro procedures were performed in 14 patients, of which, 24 patients (71.4%) were male and mean age was 53.5 years (range 27-74 years). Mean follow-up was 245 days (range 4-812 days). The primary indications for surgery include chemical or thermal injury (5 eyes), Stevens-Johnson syndrome (3 eyes), corneal amyloidosis (2 eyes), aniridia (1 eye), ocular cicatricial pemphigoid (1 eye), lupus with corneal conjunctivalization (1 eye), corneal ulcer (1 eye) and corneal scarring and vascularization of unknown cause (1 eye). Preoperative BCVA ranged from 20/100 to light perception and in 14 eyes (93.3%) vision was counting fingers or worse. No intraoperative complications occurred. Postoperative complications include retroprosthetic membrane (5 eyes), iris at back plate (2 eyes), extrusion of implant (1 eye), high intraocular pressure (1 eye), choroidal detachment (1 eye), vitreous hemorrhage (1 eye) and lower lid retraction (1 eye). Ten eyes (83.3%) achieved BCVA>20/200 and 6 eyes (50%) improved to 20/50 or better at one month follow-up (n=12). At 6 month follow-up (n=8), 7 eyes (87.5%) improved to BCVA>20/200 and 3 eyes (37.5%) were 20/50 or better. At last follow-up for all eyes, 10 eyes (66.7%) achieved BCVA>20/200 and 6 eyes (40%) improved to BCVA >20/50.

Conclusions: : The Boston KPro, based on early follow-up, is a good alternative in patients with poor prognosis for primary penetrating keratoplasty. Although complications can occur, visual outcomes improved in the vast majority of patients.

Keywords: keratoprostheses • transplantation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×